Recurrence: all 3,523 studies
Page 23 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian CancerCompletedNCT03754569Not applicable
- A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaStatus unknownNCT03751293Phase 1
- Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive QuizartinibNo longer availableNCT03746912
- Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative CareActive, not recruitingNCT03743649Phase 2/3
- ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell LymphomaCompletedNCT03742921
- Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast CancerActive, not recruitingNCT03742245Phase 1
- CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLLCompletedNCT03739554Phase 1
- Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical CancerStatus unknownNCT03738969
- Views on Physical Activity Following a Relapse in People With Multiple SclerosisCompletedNCT03736902
- Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use DisorderCompletedNCT03736317Not applicable
- Cognitive Behavioural Therapy for the Treatment of Late Life DepressionCompletedNCT03735576Not applicable
- Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 DysfunctionActive, not recruitingNCT03734198Phase 2
- Altering Toenail Biomechanic in Managing Ingrown Toenail.CompletedNCT03732313Not applicable
- FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/PaclitaxelCompletedNCT03723967Phase 2
- Endoscopic Treatment of Bronchial Carcinoid TumorsCompletedNCT03723499
- Non-invasive Vagus Nerve Stimulation for the Prevention of MigrainesCompletedNCT03716505Not applicable
- Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation StudyCompletedNCT03715660Not applicable
- A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple MyelomaTerminatedNCT03710915Phase 1
- Evaluation of Early Relapse After Mandibular Lengthening SurgeryStatus unknownNCT03710512
- Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)CompletedNCT03703167Phase 1
- Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2)Active, not recruitingNCT03703050Phase 2
- A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple MyelomaCompletedNCT03697629Phase 2
- IPD in RRMM Characterized with Genomic Abnormalities of Adverse PrognosticTerminatedNCT03683277Phase 2
- Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute LeukemiaTerminatedNCT03672851Phase 1
- Pediatric Longitudinal Cohort Study of Chronic PancreatitisCompletedNCT03672422
- Investigation of Nicotine Seeking Behavior in Current SmokersCompletedNCT03670212Phase 1
- The Relationship Between Postoperative Changes of Oral and Intestinal Flora and PrognosisStatus unknownNCT03667495
- Nimotuzumab for Recurrent Nasopharyngeal CarcinomaStatus unknownNCT03666221Phase 2
- MB-CART20.1 LymphomaCompletedNCT03664635Phase 1/2
- BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple MyelomaStatus unknownNCT03661554Early Phase 1
- Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AMLCompletedNCT03661515Phase 1
- Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)CompletedNCT03651128Phase 3
- A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell LymphomaCompletedNCT03647124
- The Biomarker Analysis in Locally Advanced Cervical CancerStatus unknownNCT03635216
- A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)Active, not recruitingNCT03634540Phase 2
- Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile SeizuresCompletedNCT03631901Phase 4
- Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer RelapseTerminatedNCT03630653Not applicable
- Creating Physical Objects With 3D Printers to Stimulate Reminiscing for Memory Loss [2 R44 AG049548-02A1]Status unknownNCT03625973Not applicable
- A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03625505Phase 1
- SIMPLE Chemotherapy for NK Lymphoma/LeukaemiaStatus unknownNCT03623087Phase 3
- A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and NeckCompletedNCT03620123Phase 2
- Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell LymphomaWithdrawnNCT03617484Phase 2
- Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung CancerStatus unknownNCT03613753Phase 2
- Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or LymphomaWithdrawnNCT03605589Phase 1
- A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid NeoplasmsStatus unknownNCT03603951Phase 1
- Pacritinib in Relapsed/Refractory Lymphoproliferative DisordersTerminatedNCT03601819Phase 1
- Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in MexicansStatus unknownNCT03601624Phase 2
- An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple MyelomaCompletedNCT03601078Phase 2
- A Worldwide Score for Hepatocellular Cancer and Liver TransplantationCompletedNCT03595345
- A Study of Anlotinib in Recurrent/Metastatic Head and Neck AdenocarcinomasStatus unknownNCT03591666Phase 2
- Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal CarcinomaStatus unknownNCT03585673Phase 2
- NGS in AML RelapseStatus unknownNCT03582241
- The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte LymphomaStatus unknownNCT03576807Phase 1
- Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCTCompletedNCT03575767
- Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI TreatmentStatus unknownNCT03573596Phase 2
- F-18 FDG- PETCT in Staging and Recurrent Colorectal CancerStatus unknownNCT03572595
- Comparison of Self Fixating Mesh to Mesh Fixation With Metallic Tacks in Laparoscopic Inguinal Hernia RepairStatus unknownNCT03564535Not applicable
- Olaparib in Recurrent IDH-mutant GliomaCompletedNCT03561870Phase 2
- Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 MutationWithdrawnNCT03560908Phase 1
- Study of BCMA CAR-T in Multiple MyelomaStatus unknownNCT03559764Early Phase 1
- Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis RelapseCompletedNCT03558529
- CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）Status unknownNCT03556982Phase 1/2
- Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple SclerosisStatus unknownNCT03552211
- Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor MicroenvironmentCompletedNCT03547388Phase 1
- Childhood Acute Lymphoblastic Leukaemia: Follow-UpCompletedNCT03545659
- CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）Status unknownNCT03544021Phase 1/2
- Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell LymphomaStatus unknownNCT03540303Phase 1
- A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.Active, not recruitingNCT03539744Phase 3
- Effect of Fertility-sparing Therapy of Early Endometrial CancerStatus unknownNCT03538704Not applicable
- A Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesCompletedNCT03538028Phase 1
- A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 ImmunotherapyActive, not recruitingNCT03525873Phase 3
- Study on the Role of FDG-PET in Patients With FL at Time of Relapse/ProgressionCompletedNCT03525665
- Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative DiagnosisStatus unknownNCT03524677
- Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT03515369Phase 4
- Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial FibrillationStatus unknownNCT03514693Not applicable
- A Study of TQ-B3525 on Tolerance and PharmacokineticsStatus unknownNCT03510767Phase 1
- A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive LymphomaCompletedNCT03505554Phase 2
- Predicting Relapse of Ulcerative Colitis With Gastrointestinal UltrasoundStatus unknownNCT03501758
- VIA Family - Family Based Early Intervention Versus Treatment as UsualCompletedNCT03497663Not applicable
- Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple MyelomaTerminatedNCT03492138Phase 1/2
- Epacadostat, Cladribine and Cytarabine (ECC) in AMLWithdrawnNCT03491579Phase 1
- MEDI2228 in Subjects With Relapsed/Refractory Multiple MyelomaCompletedNCT03489525Phase 1
- The CalproSmartNOR Study - a New Clinical Tool for Monitoring Patients With Inflammatory Bowel DiseaseCompletedNCT03486158Not applicable
- Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple MyelomaTerminatedNCT03486067Phase 1
- A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT03484520Phase 1
- A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL SubjectsCompletedNCT03483688Phase 1
- Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)CompletedNCT03477643
- Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT)Status unknownNCT03474133Phase 2
- Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.Status unknownNCT03467178Phase 2
- Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma PatientsCompletedNCT03464916Phase 1
- ASPIRIN Trial BelgiumActive, not recruitingNCT03464305Phase 3
- Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin LymphomaCompletedNCT03458260Phase 2
- Risk Factors for Recurrence After Pelvic ReconstructionCompletedNCT03457883Not applicable
- Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With ProlactinomaStatus unknownNCT03457389Not applicable
- HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD ProphylaxisTerminatedNCT03456817Phase 2
- Severe Alcohol-use Disorder: a tDCS and Response Inhibition Training InterventionCompletedNCT03447054Not applicable
- iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic SyndromesWithdrawnNCT03446638Not applicable
- Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young AdultsCompletedNCT03445858Early Phase 1
- Vinorelbine for Recurrent ALCL-2017CompletedNCT03443128Phase 2
- TCR-engineered T Cells in Solid Tumors: IMA202-101CompletedNCT03441100Phase 1